Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: The recovery trial

Journal of the American College of Cardiology

Volumn 59, Issue 25, 2012, Pages 2338-2343

  Price, Matthew J ^a   Walder, James S ^b   Baker, Brian A ^c   Heiselman, Darell E ^d   Jakubowski, Joseph A ^d   Logan, Douglas K ^e   Winters, Kenneth J ^d   Li, Wei ^c   Angiolillo, Dominick J ^f  

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b Black Hills Cardiology   (United States)

^c DAIICHI SANKYO INC   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e MedPace Clinical Pharmacology ^*  (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

bleeding; clopidogrel; platelet function; prasugrel; surgery; thienopyridine

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; THIOPHENE DERIVATIVE; TICLOPIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS REACTION; DEMOGRAPHY; DIABETES MELLITUS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECCHYMOSIS; EPISTAXIS; FEMALE; GENOTYPE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BRUISING; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; AGED; BLEEDING; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFECT; EPIDEMIOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; THROMBOCYTE;

ADULT; AGED; ASPIRIN; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; THIOPHENES; TICLOPIDINE;

EID: 84862164893     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.042     Document Type: Article

References (11)

1. J.T. Brandt, C.D. Payne, S.D. Wiviott A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 2007 66.e9 66.e16
2. T. Jernberg, C.D. Payne, K.J. Winters Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease Eur Heart J 27 2006 1166 1173
3. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
4. J.S. Berger, C.B. Frye, Q. Harshaw, F.H. Edwards, S.R. Steinhubl, R.C. Becker Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
5. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
6. R.S. Wright, J.L. Anderson, C.D. Adams 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST- elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 2022 2060
7. C. Varenhorst, S. James, D. Erlinge Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin Am Heart J 0 2009 1.e1 1.e9
8. C. Varenhorst, S. James, D. Erlinge Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease Eur Heart J 30 2009 1744 1752
9. L. Bonello, U.S. Tantry, R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
10. J.L. Ferreiro, D. Sibbing, D.J. Angiolillo Platelet function testing and risk of bleeding complications Thromb Haemost 103 2010 1128 1135
11. M.J. Price, P.S. Teirstein Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers Am J Cardiol 102 2008 790 795